|
| 2. Potential applications and benefits. A listing of potential | applications of Section 340B and the potential benefits to public, | private and 3rd-party payors for prescription drugs, including | without limitation: |
|
| A. Application to inmates and employees in youth | correctional facilities, county jails and state prisons; |
|
| B. Maximizing the use of Section 340B within state-funded | managed care plans; |
|
| C. Including Section 340B providers in state bulk | purchasing initiatives; and |
|
| D. Utilizing sole source contracts with Section 340B | providers to furnish high-cost chronic care drugs; |
|
| | 3. Section 340B discounts. Discounts available through | Section 340B contracts, including estimated costs savings to the | State as a result of retail mark-up avoidance, negotiated | subceiling prices and coordination with the MaineCare program in | order to minimize costs to the program and to other purchasers of | prescription drugs; and |
|
| | 4. Identification of resources. The resources available to | potential applicants for designation as covered entities for the | application process, establishing a Section 340B program, | restructuring the health care system or other methods of lowering | the cost of prescription drugs. The resources must include state | and federal agencies and private philanthropic grants to be used | for the purposes of this section; and be it further |
|
| | Sec. 2. Report out legislation. Resolved: That the Joint Standing | Committee on Health and Human Services may report out legislation | to the Second Regular Session of the 121st Legislature regarding | use in the State of Section 340B, restructuring the health care | system or other methods of lowering the cost of prescription | drugs. |
|
|